Showing results (311-320 of 379) with videos related to

Sort By:
Pageof 38
Arthritis Care & Research|December 6, 2012
Clinical and ultrasound-based composite disease activity indices in rheumatoid arthritis: results from a multicenter, randomized studyP Mandl, P V Balint, Y Brault, et al.
Osteoarthritis and Cartilage|July 31, 1998
Inter-observer reliability of the arthroscopic quantification of chondropathy of the kneeX Ayral, A Gueguen, R W Ike, et al.
Arthritis and Rheumatism|December 2, 2011
Metrologic properties of ultrasound versus clinical evaluation of synovitis in rheumatoid arthritis: results of a multicenter, randomized studyP Mandl, P V Balint, Y Brault, et al.
Annals of the Rheumatic Diseases|September 29, 2011
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapiesL Gossec, J S Smolen, C Gaujoux-Viala, et al.
Seminars in Arthritis and Rheumatism|July 26, 2015
Development of a multimorbidity index: Impact on quality of life using a rheumatoid arthritis cohortHelga Radner, Kazuki Yoshida, Maria Dahl Mjaavatten, et al.
Osteoarthritis and Cartilage|May 5, 2009
Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP)J F Maillefert, M Kloppenburg, L Fernandes, et al.
Annals of the Rheumatic Diseases|December 7, 2007
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexateM Schiff, M Keiserman, C Codding, et al.
Osteoarthritis and Cartilage|February 26, 2008
The development of a short measure of physical function for knee OA KOOS-Physical Function Shortform (KOOS-PS) - an OARSI/OMERACT initiativeA V Perruccio, L Stefan Lohmander, M Canizares, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 15, 2018
Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metricM A H Oude Voshaar, H E Vonkeman, D Courvoisier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2014
Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trialJ Sieper, R Landewé, M Rudwaleit, et al.
Pageof 38